Dr. Carol D Pross, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5 Ferguson Ct, Marlton, NJ 08053 Phone: 215-378-9413 |
Dr. Hamid Abdollahi, Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 11 Eves Dr, Marlton, NJ 08053 Phone: 908-751-1071 |
Cynthia West, PA-C Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 127 Church Rd, Suite 100, Marlton, NJ 08053 Phone: 856-810-9888 Fax: 856-810-9889 |
Dr. Ashish Bedi, M.D Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: Renaissance Square, 141 Route 70, Suite C, Marlton, NJ 08053 Phone: 856-355-7176 Fax: 856-762-1249 |
Mr. Dhiraj Panda, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 528 Lippincott Drive, Marlton, NJ 08053 Phone: 856-596-6100 Fax: 856-596-7507 |
News Archive
SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries.
Tibial artery calcification is a significant risk factor for foot ulcers in patients with Type 2 diabetes, research suggests.
U.S. hospitals spent $83 billion in 2008 caring for people with diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In that year, nearly one of every five hospitalizations involved a person with diabetes.
Heart attack patients who develop serious arrhythmia in connection with procedures to open blocked arteries face a significantly higher risk of death for several months after the procedure, when compared to similar patients who do not develop such complications, according to new research from Duke University Medical Center.
PrenaTest, Europe's first non-invasive molecular genetic blood test to determine fetal trisomies 13, 18 and 21 in the mother's blood can now be performed for high risk pregnancies after the ninth week (W 9 + D 0).
› Verified 9 days ago